CIPC (CLOCK Interacting Pacemaker) is a transcriptional repressor that functions as a negative-feedback regulator in circadian clock mechanisms, though its essential role in basic circadian function remains uncertain 1. The protein exhibits nuclear-cytoplasmic shuttling properties dependent on lysine residues 186-187 within its nuclear localization signal, and it interacts with key cellular proteins including the CAD enzyme involved in pyrimidine synthesis 1. Beyond circadian regulation, CIPC demonstrates versatile cellular functions by suppressing cell proliferation, causing cell cycle retardation, and inhibiting PMA-induced ERK activation in a nuclear localization-dependent manner 1. Disease relevance includes its potential role in cancer, as CIPC overexpression is associated with isochromosome 17q chr14 aberrations in medulloblastoma Groups 3 and 4 2. The gene shows differential expression patterns among medulloblastoma consensus subgroups, with associated biological pathways including ribosome function, phototransduction, and WNT signaling 2. CIPC expression can be modulated by gut microbiota modifications, as demonstrated in hypertensive models where ARB-treated microbes increased intestinal Cipc gene levels 3. Clinical significance lies in its potential as a therapeutic target, particularly in medulloblastoma where circadian clock genes including CIPC may influence patient survival outcomes 2.